Correlation Engine 2.0
Clear Search sequence regions

  • diagnosis (1)
  • empiric (1)
  • humans (1)
  • patient (2)
  • pneumonia (6)
  • procalcitonin (4)
  • Sizes of these terms reflect their relevance to your search.

    Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment. Copyright © 2023 Elsevier Inc. All rights reserved.


    Mark L Metersky, Andre C Kalil. Management of Ventilator-Associated Pneumonia: Guidelines. Infectious disease clinics of North America. 2024 Mar;38(1):87-101

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 38280768

    View Full Text